[Chemotherapy of advanced prostate cancer].
D002699:Chlorambucil / Q000031:analogs & derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000627:therapeutic use; D003606:Dacarbazine / Q000627:therapeutic use; D004054:Diethylstilbestrol / Q000627:therapeutic use; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004961:Estramustine / Q000627:therapeutic use; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D008297:Male; D009313:National Health Programs; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D011239:Prednisolone / Q000031:analogs & derivatives / Q000627:therapeutic use; D011344:Procarbazine / Q000627:therapeutic use; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D013311:Streptozocin / Q000627:therapeutic use; D013997:Time Factors; D014481:United States
D002699:Chlorambucil; D004961:Estramustine; D011344:Procarbazine; D013311:Streptozocin; D004054:Diethylstilbestrol; D003606:Dacarbazine; D003520:Cyclophosphamide; D011239:Prednisolone; D005472:Fluorouracil; D006918:Hydroxyurea
Khimioterapiia zapushchennogo raka predstatel'noĭ zhelezy.